Progress of mitochondrial and endoplasmic reticulum-associated signaling and its regulation of chronic liver disease by Chinese medicine

doi:10.4254/wjh.v16.i4.494

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (413)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

HTML

277

Figures (1-4)

Sum=312

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=70

Publishing Process of This Article

Item

Count

Browse

Download

Sum=15

Apr 27, 2024 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hepatol. Apr 27, 2024; 16(4): 494-505
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.494

Progress of mitochondrial and endoplasmic reticulum-associated signaling and its regulation of chronic liver disease by Chinese medicine

Yang Zheng, Yi-Hui Zheng, Jia-Hui Wang, Tie-Jian Zhao, Lei Wang, Tian-Jian Liang

Yang Zheng, Yi-Hui Zheng, Jia-Hui Wang, Tie-Jian Zhao, Lei Wang, Tian-Jian Liang, Department of Medicine, Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning 530222, Guangxi Zhuang Autonomous Region, China

Co-first authors: Yang Zheng and Yi-Hui Zheng.

Author contributions: Zheng Y, Zheng YH, Wang JH, Zhao TJ, Wang L and Liang TJ designed the study; Zheng Y and Zheng YH wrote the first draft; Wang JH, Zhao TJ and Wang L were responsible for the production of the images; Zheng Y and Liang TJ revised the paper; All authors have read and approve the final manuscript.

Supported by the National Natural Science Foundation of China, No. 82204755, and No. 81960751; the Guangxi Natural Science Foundation Youth Project, No. 2023GXNSFBA026274; the Guangxi University of Traditional Chinese Medicine School-level Project Youth Fund, No. 2022QN008; and Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project, No. 2022MS008 and No. 2022QJ001.

Conflict-of-interest statement: The authors declare that there are no financial conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Tian-Jian Liang, MD, Professor, Department of Medicine, Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, No. 13 Wuhe Avenue, Qingxiu District, Nanning 530222, Guangxi Zhuang Autonomous Region, China. liangtj@gxtcmu.edu.cn

Received: December 28, 2023
Peer-review started: December 28, 2023
First decision: January 27, 2024
Revised: February 3, 2024
Accepted: March 25, 2024
Article in press: March 25, 2024
Published online: April 27, 2024

Core Tip

Core Tip: Endoplasmic reticulum mitochondria-associated membranes (MAMs) play a very important role in the pathogenesis of chronic liver disease. MAMs play an important regulatory role in lipid accumulation, inflammatory response and apoptosis of cells, etc. Influencing the regulatory function of MAMs by targeting their structure can play a role in ameliorating chronic liver disease, which provides new perspectives and research directions for the development of new therapeutic approaches for chronic liver disease.